Testing effectiveness (Phase 2)Study completedNCT00035607What this trial is testingChemotherapy Related AnemiaWho this might be right forAnemiaNon-Myeloid Malignancies Amgen 120
Testing effectiveness (Phase 2)Ended earlyNCT02075463What this trial is testingStudy to Evaluate the Safety and Efficacy of GSK1278863 in Recombinant Human Erythropoietin (rhEPO) Hyporesponsive Hemodialysis-dependent Chronic Kidney Disease Subjects With AnemiaWho this might be right forAnemiaAnaemia GlaxoSmithKline 15
Large-scale testing (Phase 3)Study completedNCT03350321What this trial is testingMolidustat for Correction of Renal Anemia in Non-dialysis SubjectsWho this might be right forAnemiaRenal Insufficiency, Chronic Bayer 162
Testing effectiveness (Phase 2)Ended earlyNCT03140722What this trial is testingStudy to Evaluate Vadadustat for Anemia in Subjects With Dialysis-Dependent Chronic Kidney Disease (DD-CKD) Who Are Hyporesponsive to Erythropoiesis Stimulating AgentsWho this might be right forAnemiaDialysis-Dependent Chronic Kidney Disease Akebia Therapeutics 2
Testing effectiveness (Phase 2)Ended earlyNCT00968617What this trial is testingMK2578 in Patients With Chronic Kidney Disease Who Are Not on Dialysis (2578-002)Who this might be right forAnemiaChronic Kidney Disease Merck Sharp & Dohme LLC 7
Large-scale testing (Phase 3)Study completedNCT01581073What this trial is testingPRevention of End Stage Kidney Disease by Darbepoetin Alfa In Chronic Kidney Disease Patients With nondiabeTic Kidney DiseaseWho this might be right forChronic Kidney DiseaseDiabetes Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan 476
Testing effectiveness (Phase 2)UnknownNCT00039884What this trial is testingWill Radiation/Chemotherapy Treatment of Cervical Cancer Work Better With Medication That May Improve Anemia?Who this might be right forAnemiaCervix Neoplasms Mirhashemi, Ramin, M.D. 64
Not applicableStudy completedNCT04185519What this trial is testingA Model of Computer-assisted Prescription of Erythropoiesis-stimulating Agents (ESA) in Patients Under HemodialysisWho this might be right forEnd Stage Renal Disease Kaohsiung Medical University Chung-Ho Memorial Hospital 126
Testing effectiveness (Phase 2)Study completedNCT01235923What this trial is testingRandomized Study of Weekly Erythropoietin Dosing in Preterm InfantsWho this might be right forPreterm Infants University of New Mexico 20
Testing effectiveness (Phase 2)Study completedNCT02019719What this trial is testingStudy to Evaluate the Safety, Efficacy and Pharmacokinetics of GSK1278863 in Japanese Hemodialysis-Dependent Subjects With Anemia Associated With Chronic Kidney DiseaseWho this might be right forAnaemia GlaxoSmithKline 97
Large-scale testing (Phase 3)Study completedNCT03543657What this trial is testingMaintenance Treatment of Renal Anemia in Dialysis SubjectsWho this might be right forAnemiaRenal Insufficiency, Chronic Bayer 229
Not applicableStudy completedNCT00723112What this trial is testingThe Role of Erythropoietin in Myelodysplastic SyndromeWho this might be right forMyelodysplastic Syndrome University of Utah 8
Post-approval studies (Phase 4)UnknownNCT05719376What this trial is testingThe Effect of Intravenous Iron Therapy and Erythropoiesis-stimulation Agent Combination on Renal Transplant OutcomesWho this might be right forKidney Failure, Chronic Yonsei University 302
Not applicableNot Yet RecruitingNCT06946004What this trial is testingNormobaric Oxygen Therapy in Colorectal Cancer PatientsWho this might be right forColorectal Cancer (CRC) 4th Military Clinical Hospital with Polyclinic, Poland 254
Large-scale testing (Phase 3)Study completedNCT03029208What this trial is testingAnemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-in Incident Dialysis (ASCEND-ID)Who this might be right forAnaemia GlaxoSmithKline 312
Testing effectiveness (Phase 2)Study completedNCT01977573What this trial is testingEvaluate Safety and Efficacy of GSK1278863 in Non-Dialysis Dependent (NDD) Subjects With Anemia Associated With Chronic Kidney Diseases (CKD)Who this might be right forAnaemia GlaxoSmithKline 252
Testing effectiveness (Phase 2)Study completedNCT03457701What this trial is testingAnemia Studies in CKD: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat- Iron (ASCEND: Fe)Who this might be right forAnaemia GlaxoSmithKline 15
Not applicableStudy completedNCT02987465What this trial is testingEvaluating the Effect of Standard-of-care Erythropoiesis-stimulating Agents on Forearm Blood Flow in Nondialysis-dependent Subjects With Anaemia Associated With Chronic Kidney Disease.Who this might be right forCardiovascular DiseasesChronic Kidney Disease Cambridge University Hospitals NHS Foundation Trust 29
Not applicableEnded earlyNCT01546337What this trial is testingSearch for Predictive Markers of Efficacy of ESAs in Patients With Non-myeloid Malignancies or Myelodysplastic SyndromeWho this might be right forMyelodysplastic SyndromesAnemiaHemopathies Rennes University Hospital 30
Not applicableStudy completedNCT04744181What this trial is testingPatient Blood Management In CARdiac sUrgical patientSWho this might be right forAnemiaBlood Loss AnemiaIron-deficiency+3 more Fondazione Policlinico Universitario Agostino Gemelli IRCCS 479